Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting.

Lohmueller JJ, Ham JD, Kvorjak M, Finn OJ.

Oncoimmunology. 2017 Oct 26;7(1):e1368604. doi: 10.1080/2162402X.2017.1368604. eCollection 2017.

2.

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential.

Lohmueller JJ, Sato S, Popova L, Chu IM, Tucker MA, Barberena R, Innocenti GM, Cudic M, Ham JD, Cheung WC, Polakiewicz RD, Finn OJ.

Sci Rep. 2016 Aug 22;6:31740. doi: 10.1038/srep31740.

Supplemental Content

Support Center